Basic Information
LncRNA/CircRNA Name | SNHG17 |
Synonyms | NA |
Region | GRCh38_20:38420588-38435353 |
Ensemble | ENSG00000196756 |
Refseq | NR_015366 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | melanoma |
ICD-0-3 | NA |
Methods | qRT-PCR , Luciferase reporter assay , Western blot , in vitro knockdown etc. |
Sample | melanoma tissues and matched normal tissues ,melanoma cell lines(A375, A865, CHL-1,SK-MEL-2) ,melanocyte cell line HEMa-LP ,HT144 |
Expression Pattern | up-regulated |
Function Description | High expressions of SNHG17 were observed in both melanoma tissues and cells. Up-regulation of SNHG17 in melanoma patients was associated with lymph node metastasis and tumor stage. Patients with high SNHG17 expression had significantly shorter survival time. SNHG17 was also confirmed to be independently associated with overall survival of melanoma patients. The proliferation, migration, and invasion of melanoma cells were noticeably reduced by the down-regulation of SNHG17.The up-regulation of SNHG17 was induced by STAT3. We also found that knockdown of SNHG17 resulted in the remarkable diminution in the phosphorylation levels of PI3K and AKT, suggesting that the activity of the PI3K-AKT pathway was suppressed. |
Pubmed ID | 31599425 |
Year | 2019 |
Title | STAT3-induced Upregulation of lncRNA SNHG17 Predicts a Poor Prognosis of Melanoma and Promotes Cell Proliferation and Metastasis Through Regulating PI3K-AKT Pathway |
External Links
Links for SNHG17 | GenBank HGNC NONCODE |
Links for melanoma | OMIM COSMIC |